Pamela Ralph
Child & Adolescent Psychiatry · Philadelphia, PANPI 1205953858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations.
Across 177 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$567
- Takeda Pharmaceuticals U.S.A., Inc.$459
- Otsuka America Pharmaceutical, Inc.$412
- Lundbeck LLC$262
- Johnson & Johnson$214
- Alkermes, Inc.$155
- plus $818 from 12 others
What the payments were for
- Food & beverage$2,85899%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $567 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $459 |
| Otsuka America Pharmaceutical, Inc. | 26 | $412 |
| Lundbeck LLC | 15 | $262 |
| Johnson & Johnson | 12 | $214 |
| Alkermes, Inc. | 7 | $155 |
| Tris Pharma Inc | 8 | $130 |
| Neurocrine Biosciences, Inc. | 6 | $125 |
| Vertical Pharmaceuticals, LLC | 6 | $104 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $92 |
| Sunovion Pharmaceuticals Inc. | 5 | $88 |
| Neos Therapeutics, LP | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $52 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Ironshore Pharmaceuticals Inc. | 2 | $26 |
| Shire North American Group Inc | 2 | $26 |
How this compares
$2,888 in reported general payments places this provider in the 85th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Other child & adolescent psychiatry in Philadelphia
- Thomas WindPhiladelphia$17K
- Laura AdangPhiladelphia$15K
- Christoph LamPhiladelphia$13K
- Mahendra PatilPhiladelphia$7K
- David LopezPhiladelphia$3K
- Fathima MusthaqPhiladelphia$2K
- Michael InestaPhiladelphia$1K
- Stacy McAllisterPhiladelphia$1K
- Alejandra WortmanPhiladelphia$812
- Dennis BorczonErie$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.